@article{TLCR2989,
author = {Christoph C. Zielinski},
title = {A phase I study of MEDI4736, NNT-PD-L1 antibody in patients with advanced solid tumors},
journal = {Translational Lung Cancer Research},
volume = {3},
number = {6},
year = {2014},
keywords = {},
abstract = {A review and critical consideration of immunotherapeutical concepts in non-small cell lung cancer (NSCLC) is given. Nivolumab represents a promising option in various malignancies with more results exceeding treatment of metastatic malignant melanoma eagerly awaited.},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/2989}
}